Sepofarsen

Sepofarsen Uses, Dosage, Side Effects, Food Interaction and all others data.

Sepofarsen is under investigation in clinical trial NCT03913143 (A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)).

Trade Name	Sepofarsen
Generic	Sepofarsen
Sepofarsen Other Names	Sepofarsen
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here Sepofarsen